Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 09, 2026 11:20 ET | Source: SEED Therapeutics

SEED Therapeutics Doses First Patient in Phase 1 Trial of ST-01156, a Molecular Glue Degrader Targeting RBM39

First-in-human study evaluates safety, pharmacokinetics, biomarker analyses, target engagement, and anti-tumor activity in patients with advanced solid tumors ST-01156 has received U.S. FDA Orphan...
January 09, 2026 11:00 ET | Source: Momcozy

Momcozy Reflects on a Year of Community, Connection, and Support for Mothers

Los Angeles, CA , Jan. 09, 2026 (GLOBE NEWSWIRE) -- Momcozy today released its annual recap video, marking a year defined by meaningful connection, community engagement, and expert collaboration in...
January 09, 2026 10:30 ET | Source: Novartis Pharma AG

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

New 35,000-square-foot facility in Winter Park will expand RLT manufacturing footprint to optimize delivery for patients across southeastern USPurpose-built facility will strengthen Novartis RLT...
January 09, 2026 10:30 ET | Source: Novartis Pharma AG

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

New 35,000-square-foot facility in Winter Park will expand RLT manufacturing footprint to optimize delivery for patients across southeastern USPurpose-built facility will strengthen Novartis RLT...
January 09, 2026 09:25 ET | Source: Ping An Biomedical Co., Ltd.

Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry

Ping An Biomedical (NASDAQ: PASW) will invest in Future Biotechnology Group to enhance AI-driven biopharma R&D and strengthen industry synergy.
January 09, 2026 09:00 ET | Source: CLOUDASTRUCTURE, INC.

Cloudastructure Launches AI-Powered Security Enclosure

PALO ALTO, CA, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Cloudastructure, Inc. (Nasdaq: CSAI) (“we,” “us,” “our,” “Cloudastructure” or the “Company”), a leader in AI-powered video surveillance and remote...
January 09, 2026 09:00 ET | Source: Akari Therapeutics Plc

Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026

Access the Akari CEO Corner here TAMPA, Fla. and LONDON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payloads for...
January 09, 2026 08:55 ET | Source: Senti Biosciences, Inc.

Senti Bio to Participate in Panel Presentation at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene...
January 09, 2026 08:30 ET | Source: Liberty Star Uranium & Metals Corp.

Liberty Star Minerals Publishes Letter to Shareholders from Board Chairman Pete O’Heeron

TUCSON, AZ, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Liberty Star Minerals | Liberty Star Uranium & Minerals Corp. (OTCQB: LBSR) a U.S. exploration company focused on strategic and commercially...
January 09, 2026 08:30 ET | Source: Tenaya Therapeutics, Inc.

Tenaya Therapeutics Announces 2026 Strategic Priorities and Anticipated Milestones

Aims to Build on Positive 2025 Interim TN-201 Results in First Half of 2026 with Longer-Term Follow-Up Data for Cohorts 1 and 2 from MyPEAK™-1 Trial of Adults with MYBPC3-Associated HCM Expects to...